Orexin A, Orexin B and DSIP: peptides for sleep and wakefulness research

Sleep and wakefulness as separate research questions

The sleep-wake rhythm is one of the best described biological rhythms. A biological clock in the hypothalamus drives it, and its course depends on several messenger systems. Two of them, the orexin system and the peptide DSIP, have for years been among the most discussed threads in sleep research. Below we compare three reagents that share this field: Orexin A, Orexin B and DSIP. Each has a different structure and a different starting point in the literature, so the choice depends on the question the team wants to answer.

The common ground is simple. All three are short peptides supplied as lyophilised powder with a purity of at least 99%, confirmed by HPLC, with mass confirmed by MS.

Orexin A: 33 amino acids and two receptors

Orexin A, also called hypocretin-1, is a neuropeptide produced by neurons of the lateral hypothalamus. It consists of 33 amino acid residues, and two disulfide bridges stabilise its three-dimensional structure. It was identified in the late 1990s, almost at the same time as its partner peptide. Orexin A is available in the shop as a 10 mg lyophilised vial.

In research, Orexin A is described as binding two G protein coupled receptors, OX1R and OX2R. Activation of these receptors triggers pathways that depend on intracellular calcium. For this reason the peptide is used as a tool to describe orexin signalling in cell cultures and tissue models.

Orexin B: a shorter molecule with a different profile

Orexin B, also called hypocretin-2, comes from the same precursor as Orexin A, but its chain has 28 amino acids. The difference in length and sequence translates into a different receptor binding profile. The literature describes a clear preference of Orexin B for OX2R, while it binds OX1R more weakly. Orexin B therefore makes it possible to plan an experiment that compares both receptors.

Because both peptides arise from one precursor and their actions are described against the same receptors, it makes sense to plan their use together. This avoids a situation where a comparison involves different experimental conditions.

A sensible design places both orexins in one project. Orexin A shows the response at both receptors, while Orexin B tests whether the observed result shifts toward OX2R. Such a setup only makes sense when the team prepares control groups and clearly defines the criteria for evaluation.

DSIP: a nonapeptide with a history in sleep research

DSIP, or delta sleep-inducing peptide, is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Nine residues joined by peptide bonds form a molecule short enough that its synthesis and purity control are simpler than for longer proteins. The name comes from early experiments in which changes in delta wave activity were observed on the EEG recording.

Studies in animal models have described a link between DSIP and sleep-wake rhythms. Preclinical work has also analysed its effect on the hypothalamic-pituitary-adrenal axis and on the stress response. In the laboratory, DSIP is sometimes used as a reference point in work on short peptide sequences, especially where solution stability and ease of preparation matter. Its mechanism of action has not been fully explained, and the literature still debates receptors and signalling pathways. For this reason, research teams treat DSIP as a tool for precise questions rather than as a molecule with an established activity profile.

Transitions between sleep and wakefulness result from the cooperation of many structures, not from a single messenger. Research projects in this area therefore often combine electrophysiological measurements with behavioural analysis and an assessment of neuron state. In such a system, peptide reagents serve as precise tools that let the team test one hypothesis at a time.

Comparison at a glance

Feature	Orexin A	Orexin B	DSIP
Chain length	33 amino acids	28 amino acids	9 residues (nonapeptide)
Receptors described in research	OX1R and OX2R	clear preference for OX2R	mechanism not fully explained
Form	lyophilised	lyophilised	lyophilised
Purity	at least 99% (HPLC)	at least 99% (HPLC)	at least 99% (HPLC)
Typical research areas	orexin signalling, neuronal activation	sleep-wake rhythm in models, feeding behaviour	sleep-wake rhythm, stress axis

Matching the peptide to the research question

• A question about orexin receptors: Orexin A as a ligand for both receptors, and Orexin B if the preference for OX2R is the focus.
• A question about the sleep-wake rhythm in animal models: all three reagents appear in this area, and the choice depends on whether the emphasis is orexin signalling or a peptide with a different mechanism.
• A question about the stress axis and neuroendocrinology: DSIP, with a cautious description of results and no conclusions beyond the data.

For each of these questions, write down the success criteria before the series starts. This makes it possible to tell a result that matches the hypothesis from one that merely looks promising.

Batch documentation and reproducibility

Reproducibility is one of the most common problems when working with peptides. Differences between series, even small ones, can change the outcome of a comparison, so keep a record for every vial: batch number, opening date, reconstitution method, solution volume and the date the working aliquots were prepared. The batch number printed on the vial links a result to a specific material. Such documentation also makes it easier to compare results with other teams and to write the methods section.

In practice this comes down to one simple rule: each arm of an experiment should use the same reagent batch, and if the batch changes, the change must be recorded and taken into account in the analysis. This applies to Orexin A, Orexin B and DSIP alike.

Ordering and dispatch

All three products are available as lyophilised powder with a purity of at least 99%, confirmed by HPLC, with mass confirmed by MS. Orders are dispatched within 24 hours. In Poland we ship through InPost parcel lockers, and across Europe by DPD courier. This makes it easier to schedule delivery of reagents around a concrete research timetable.

Working in the laboratory

Orexin A, Orexin B and DSIP are reagents for scientific and laboratory research. They are not intended for use in humans or animals. Store the lyophilisate at -20 °C, tightly closed and protected from light. Before opening a vial, let it reach room temperature so that moisture does not condense inside. Reconstitute with sterile bacteriostatic water and keep the ready solution at 2-8 °C. Avoid repeated freezing and thawing by dividing the solution into working aliquots. Calculate the working concentration in the concentration calculator before starting a series of measurements.